SREBF1 and neoplasm: SREBF1/2 KD reduced de novo lipogenesis from acetate (Fig. 6b) and tumor growth in vivo (Fig. 6c, d), whereas the overexpression of mature SREBP1/2 increased lipogenesis and tumor growth (Fig. 6b–d).